593 results on '"Nunes, Marta C"'
Search Results
52. Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials
53. Proteomic profiling of urine from hospitalised patients with severe pneumonia due to SARS-CoV-2 versus other causes: a preliminary report
54. Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN)
55. Patient influenza vaccination reduces the risk of hospital-acquired influenza: An incident test negative-case control study in Lyon university hospital, France (2004–2020)
56. The Burden of Pertussis Hospitalization in HIV-Exposed and HIV-Unexposed South African Infants
57. Bordetella pertussis Infection in South African HIV-Infected and HIV-Uninfected Mother–Infant Dyads: A Longitudinal Cohort Study
58. Comparing the Yield of Nasopharyngeal Swabs, Nasal Aspirates, and Induced Sputum for Detection of Bordetella pertussis in Hospitalized Infants
59. Epidemiology of community-acquired pneumonia caused by Streptococcus pneumoniaein older adults: a narrative review
60. Immunogenicity of 13-valent pneumococcal conjugate vaccine among children with underlying medical conditions
61. Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis
62. Age Differences in Comorbidities, Presenting Symptoms, and Outcomes of Influenza Illness Requiring Hospitalization: A Worldwide Perspective From the Global Influenza Hospital Surveillance Network
63. Streptococcus pneumoniae and other bacterial nasopharyngeal colonisation eight years post-introduction of 13-valent pneumococcal conjugate vaccine in South African children.
64. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
65. Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data
66. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
67. Adverse maternal, fetal, and newborn outcomes among pregnant women with SARS-CoV-2 infection: an individual participant data meta-analysis
68. Kinetics of Hemagglutination-Inhibiting Antibodies Following Maternal Influenza Vaccination Among Mothers With and Those Without HIV Infection and Their Infants
69. Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)
70. Epidemiology of All-Cause and Endemic Respiratory Virus Associated Lower Respiratory Tract Infection Hospitalization in Children During the Covid-19 Pandemic (2020-2022) Compared with the Pre-Pandemic Period (2015-2019) in South Africa: An Observational Study
71. Influenza
72. Longitudinal study on Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus nasopharyngeal colonization in HIV-infected and -uninfected infants vaccinated with pneumococcal conjugate vaccine
73. Acquisition of Streptococcus pneumoniae in South African children vaccinated with 7-valent pneumococcal conjugate vaccine at 6, 14 and 40 weeks of age
74. Antepartum SARS-CoV-2 infection and adverse birth outcomes in South African women
75. Age differences in comorbidities, presenting symptoms, and outcomes of influenza illness requiring hospitalization: A worldwide perspective from the global influenza hospital surveillance network
76. Temporal Changes in Pneumococcal Colonization in HIV-infected and HIV-uninfected Mother-Child Pairs Following Transitioning From 7-valent to 13-valent Pneumococcal Conjugate Vaccine, Soweto, South Africa
77. Increased severity of influenza-associated hospitalizations in resource-limited settings: Results from the Global Influenza Hospital Surveillance Network (GIHSN)
78. Identifying the research, advocacy, policy and implementation needs for the prevention and management of respiratory syncytial virus lower respiratory tract infection in low- and middle-income countries
79. Further Cautions When Modeling the Public Health Impact of Infectious Diseases
80. Human Metapneumovirus-Associated Hospitalization in HIV-1 Exposed Uninfected and HIV-1 Uninfected Children Less Than 5 Years in South Africa
81. Active Intrapartum SARS-CoV-2 Infection and Pregnancy Outcomes
82. Evolution of the Gut Microbiome in HIV-Exposed Uninfected and Unexposed Infants during the First Year of Life
83. T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa
84. Effectiveness of Influenza Vaccination of Pregnant Women for Prevention of Maternal and Early Infant Influenza-Associated Hospitalizations in South Africa: A Prospective Test-Negative Study
85. Coronavirus Host Genomics Study: South Africa (COVIGen-SA)
86. Maternal–foetal transfer of severe acute respiratory syndrome coronavirus 2 antibodies among women with and those without HIV infection
87. T-cell responses to SARS-CoV-2 in unexposed South African women
88. Clinical risk factors of adverse outcomes among women with COVID-19 in the pregnancy and postpartum period: a sequential, prospective meta-analysis
89. How host heterogeneity governs tuberculosis reinfection?
90. Influenza Vaccination Results in Differential Hemagglutinin Stalk-Specific Fc-Mediated Functions in Individuals Living With or Without HIV
91. Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
92. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
93. Clinical characteristics and histopathology of COVID-19 related deaths in South African adults
94. T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa.
95. Supplement to: Influenza vaccination of pregnant women and protection of their infants.
96. T-cell responses to SARS-CoV-2 in unexposed South African women
97. Influenza epidemiology and influenza vaccine effectiveness during the 2016–2017 season in the Global Influenza Hospital Surveillance Network (GIHSN)
98. SARS-CoV-2 infection among healthcare workers in South Africa: a longitudinal cohort study
99. Influenza Vaccination of Pregnant Women and Protection of Their Infants
100. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.